Michael P Chapman
Overview
Explore the profile of Michael P Chapman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrell M, Moore E, Thomas A, Coleman J, Thomas S, Vande Lune S, et al.
Am Surg
. 2021 Feb;
88(7):1689-1693.
PMID: 33629880
Background: Improvements in health care innovations have resulted in an enhanced ability to extend patient viability. As a consequence, resources are being increasingly utilized at an unsustainable level. As we...
2.
Barrett C, Moore H, Vigneshwar N, Dhara S, Chandler J, Chapman M, et al.
J Trauma Acute Care Surg
. 2020 Nov;
89(6):991-998.
PMID: 33230046
Background: Trauma patients with hyperfibrinolysis and depletion of fibrinolytic inhibitors (DFIs) measured by thrombelastography (TEG) gain clot strength with TXA, but TEG results take nearly an hour. We aimed to...
3.
Schulick A, Moore H, Walker C, Yaffe H, Pomposelli J, Azam F, et al.
Am J Surg
. 2020 Sep;
220(6):1379-1386.
PMID: 32907709
Background: An NIH clinical coagulopathy score has been devised for trauma patients, but no such clinical score exists in transplantation surgery. We hypothesize that that this coagulopathy score can effectively...
4.
Moore H, Yaffe H, Pomposelli J, Wachs M, Bak T, Kennealey P, et al.
Am J Surg
. 2020 Sep;
220(6):1518-1525.
PMID: 32907708
Introduction: During the anhepatic phase of liver transplantation (LT), fibrinolytic activity increases, since the liver clears tissue plasminogen activator (tPA). We hypothesize that patients who fail to reduce fibrinolytic activity...
5.
Walker C, Moore H, Nydam T, Schulick A, Yaffe H, Pomposelli J, et al.
Am J Surg
. 2020 Sep;
220(6):1511-1517.
PMID: 32878689
Background: End stage renal disease (ESRD) is associated with elevated fibrinogen levels and fibrinolysis inhibition. However, there is a paucity of data on how renal transplantation impacts coagulation. we hypothesize...
6.
Coleman J, Moore E, Moore H, Chapman M, Cohen M, Silliman C, et al.
ANZ J Surg
. 2020 Apr;
90(4):420-422.
PMID: 32339428
No abstract available.
7.
Moore H, Tessmer M, Moore E, Sperry J, Cohen M, Chapman M, et al.
J Trauma Acute Care Surg
. 2020 Apr;
88(5):588-596.
PMID: 32317575
Background: Randomized clinical trials (RCTs) support the use of prehospital plasma in traumatic hemorrhagic shock, especially in long transports. The citrate added to plasma binds with calcium, yet most prehospital...
8.
Chapman M, Moore E, Moore H, Sauaia A
Lancet
. 2020 Feb;
395(10224):562-563.
PMID: 32087789
No abstract available.
9.
Pusateri A, Moore E, Moore H, Le T, Guyette F, Chapman M, et al.
JAMA Surg
. 2019 Dec;
155(2):e195085.
PMID: 31851290
Importance: Both military and civilian clinical practice guidelines include early plasma transfusion to achieve a plasma to red cell ratio approaching 1:1 to 1:2. However, it was not known how...
10.
Coleman J, Moore E, Sauaia A, Samuels J, Moore H, Ghasabyan A, et al.
Ann Surg
. 2019 Dec;
271(6):e128-e130.
PMID: 31850983
No abstract available.